Skip to content
Baret News – Lifestyle
Author:
NovaBridge Biosciences
NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer
June 16, 2026
NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
May 20, 2026
←
Previous Page
1
2